Synergistic fluvastatin-nanotherapy suppresses DEPDC1-associated glycolysis and exosomal CCL2 to modulate the immune microenvironment in lung adenocarcinoma.

Li C, Lyu X, Kang T, Zhang X, Zhou L, Wang Y, Wei Z, Huang Y, Yuan C, Zhang Z, Wei L, Li K, Dong M

DOI: 10.1186/s12951-026-04829-w
Published: 2026 Jul 28
Container: Journal of nanobiotechnology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s12951-026-04829-w,
  title = {Synergistic fluvastatin-nanotherapy suppresses DEPDC1-associated glycolysis and exosomal CCL2 to modulate the immune microenvironment in lung adenocarcinoma.},
  author = {Li C and Lyu X and Kang T and Zhang X and Zhou L and Wang Y and Wei Z and Huang Y and Yuan C and Zhang Z and Wei L and Li K and Dong M},
  year = {2026},
  journal = {Journal of nanobiotechnology},
  doi = {10.1186/s12951-026-04829-w},
  url = {https://doi.org/10.1186/s12951-026-04829-w}
}

RIS

TY  - JOUR
TI  - Synergistic fluvastatin-nanotherapy suppresses DEPDC1-associated glycolysis and exosomal CCL2 to modulate the immune microenvironment in lung adenocarcinoma.
AU  - Li C
AU  - Lyu X
AU  - Kang T
AU  - Zhang X
AU  - Zhou L
AU  - Wang Y
AU  - Wei Z
AU  - Huang Y
AU  - Yuan C
AU  - Zhang Z
AU  - Wei L
AU  - Li K
AU  - Dong M
PY  - 2026
JO  - Journal of nanobiotechnology
DO  - 10.1186/s12951-026-04829-w
UR  - https://doi.org/10.1186/s12951-026-04829-w
ER  -

APA

C, L., X, L., T, K., X, Z., L, Z., Y, W., Z, W., Y, H., C, Y., Z, Z., L, W., K, L., & M, D. (2026). Synergistic fluvastatin-nanotherapy suppresses DEPDC1-associated glycolysis and exosomal CCL2 to modulate the immune microenvironment in lung adenocarcinoma.. Journal of nanobiotechnology. https://doi.org/10.1186/s12951-026-04829-w

Source records

pubmed · retrieved 2026-11-10T16:37:58.170Z